vTv Therapeutics (VTVT) Income from Non-Controlling Interests (2015 - 2025)

vTv Therapeutics has disclosed Income from Non-Controlling Interests across 11 years of filings, most recently posting -$1.6 million for Q3 2025.

• Income from Non-Controlling Interests for Q3 2025 came in at -$1.6 million, down 55.82% year-over-year; the trailing twelve-month figure through Mar 2026 was -$3.0 million (up 29.26% YoY), and the FY2025 annual result was -$4.1 million, up 3.23% from the prior year.
• Income from Non-Controlling Interests came in at -$1.6 million for Q3 2025 at vTv Therapeutics, down from -$1.3 million in the prior quarter.
• In the past five years, Income from Non-Controlling Interests ranged from a high of -$233000.0 in Q2 2021 to a low of -$2.4 million in Q4 2021.
• The 5-year median for Income from Non-Controlling Interests is -$1.2 million (2024), against an average of -$1.3 million.
• Peak annual rise in Income from Non-Controlling Interests reached 85.64% in 2021, while the deepest fall reached 605.61% in 2021.
• vTv Therapeutics' Income from Non-Controlling Interests stood at -$2.4 million in 2021, then soared by 44.7% to -$1.3 million in 2022, then grew by 28.4% to -$963000.0 in 2023, then increased by 16.61% to -$803000.0 in 2024, then tumbled by 105.11% to -$1.6 million in 2025.
• The last three Income from Non-Controlling Interests figures came in at -$1.6 million (Q3 2025), -$1.3 million (Q2 2025), and -$1.1 million (Q1 2025), per Business Quant data.